News Desk :
Bangladesh has approved the emergency use of China’s Sinopharm Covid-19 vaccine.
Director General of Drug Administration (DGDA) Maj Gen Mahbubur Rahman came up with the announcement at a press briefing on Thursday.
“We have seen the review and phase 1, phase 2 reports of our technical committee. We have approved the Sinopharm vaccine and authorised its emergency use,” he added
He also said that China will provide 500,000 doses of the Sinopharm vaccine in the first phase. The first shipment of will arrive in Bangladesh within two weeks, he added.
“The vaccine will be procured on G2G basis,” he added.
Mahbubur Rahman also noted that government-level talks are taking place on manufacturing the Sinopharm vaccine in the country. He further said the health department will vaccinate 1,000 people in the beginning and observe the effect.
“We will start mass vaccination after the observation period,” said DGDA DG.
Second dose will be administered after 28 days of the first dose of this vaccine.
Earlier on Tuesday, the DGDA approved Russia’s Sputnik V Covid-19 vaccine for emergency use in Bangladesh.
